Fig. 3: Kaplan-Meier survival curves for patients undergoing direct hepatectomy or neoadjuvant triple therapy followed by hepatectomy. | Communications Medicine

Fig. 3: Kaplan-Meier survival curves for patients undergoing direct hepatectomy or neoadjuvant triple therapy followed by hepatectomy.

From: Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002)

Fig. 3: Kaplan-Meier survival curves for patients undergoing direct hepatectomy or neoadjuvant triple therapy followed by hepatectomy.

a Overall survival in the entire study sample; b event-free survival in the entire study sample; c overall survival in propensity score-matched subgroups; d event-free survival in propensity score-matched subgroups. CI confidence interval; neoadjuvant triple therapy, neoadjuvant transarterial chemoembolization combined with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Back to article page